BK Virus Infection Clinical Trial Key BK Virus Infection Companies are AiCuris Anti-infective Cures AG, Memo Therapeutics AG, Vera Therapeutics, and others. The BK Virus (BKV) Infection therapeutic landscape is
Asthma Clinical Trials Key Asthma Companies include Generate Biomedicines, AstraZeneca, Enveda, Celldex Therapeutics, SinoMab BioScience Ltd, Pfizer, Sanofi, Amgen, and others The global asthma therapeutic landscape is undergoing a profound
Costway, a home and lifestyle brand, recently highlighted its complete cooling lineup for everyday comfort. From mini split air conditioners to spray-type ice makers, Costway’s broader cooling lineup gives households
Hyperoxaluria Clinical Trial Key Hyperoxaluria Companies include Arbor Biotechnologies, META Pharmaceuticals, Biocodex, and many more The Hyperoxaluria therapeutic landscape is witnessing a transformative shift, driven by cutting-edge research and the
Hypersomnia Clinical Trial Key Hypersomnia Companies are Takeda, Centessa Pharmaceuticals, Alkermes, and others The Hypersomnia therapeutic landscape is undergoing a gradual yet meaningful transformation, driven by increasing clinical research, deeper
The platform detects DNS blocks, HTTP filtering, and SSL certificate restrictions across 50+ countries with alerts delivered via Telegram. Domainreach has launched a domain monitoring service built around a simple
There are 70+ key companies, including Belite Bio, Alkeus Pharmaceuticals, Stealth BioTherapeutics, Ocugen, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Roche, and Novartis, developing therapies for Dry Age-Related Macular Degeneration.
Hanzhi Jiuye recently announced the acceleration of its expansion in the U.S. market. The company has obtained the required licenses to support its U.S. alcohol distribution operations and currently focuses
Antisense Oligonucleotide Therapeutics Pipeline Insight The Antisense Oligonucleotide landscape features 70+ key companies, including Novartis, Wave Life Sciences, Bio-Path Holdings, and others, advancing over 90 pipeline drugs. Companies like Novartis
Acute Lymphocytic Leukemia (ALL) Pipeline Insight There are 120+ key companies, including Ascentage Pharma, Hebei Senlang Biotechnology, Amgen, Servier, Beam Therapeutics, Janssen, Orca Bio, and others, developing therapies for Acute
